Neurocrine Biosciences Inc (NBIX) — Financial Flexibility Index
Neurocrine Biosciences Inc (NBIX) has a Financial Flexibility Index of 0.28x as of December 2025. Free cash flow of $390.80 Million (operating CF $388.40 Million minus capex $2.40 Million) represents 0% of total liabilities ($1.38 Billion). Check how aggressively does Neurocrine Biosciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neurocrine Biosciences Inc Financial Flexibility Index (1996–2025)
Historical Financial Flexibility Index trend for Neurocrine Biosciences Inc across 30 annual periods. For the full cash flow conversion analysis, see Neurocrine Biosciences Inc (NBIX) cash conversion ratio.
Annual Financial Flexibility Index for Neurocrine Biosciences Inc (1996–2025)
Year-by-year free cash flow to debt coverage for Neurocrine Biosciences Inc. Explore NBIX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | $816.70 Million | $782.70 Million | $1.38 Billion | ▲ +5.6% |
| 2024 | 0.56x | $633.60 Million | $595.40 Million | $1.13 Billion | ▲ +36.8% |
| 2023 | 0.41x | $418.20 Million | $389.90 Million | $1.02 Billion | ▼ -23.8% |
| 2022 | 0.54x | $355.90 Million | $339.40 Million | $660.90 Million | ▲ +34.4% |
| 2021 | 0.40x | $279.90 Million | $256.50 Million | $698.50 Million | ▲ +1.9% |
| 2020 | 0.39x | $239.40 Million | $228.50 Million | $608.50 Million | ▲ +62.8% |
| 2019 | 0.24x | $161.70 Million | $147.00 Million | $669.10 Million | ▼ -1.9% |
| 2018 | 0.25x | $126.20 Million | $101.40 Million | $512.39 Million | ▲ +225.5% |
| 2017 | -0.20x | $-87.39 Million | $-94.33 Million | $445.45 Million | ▲ +90.3% |
| 2016 | -2.03x | $-102.07 Million | $-106.18 Million | $50.21 Million | ▼ -183.7% |
| 2015 | -0.72x | $-36.06 Million | $-38.00 Million | $50.33 Million | ▲ +46.0% |
| 2014 | -1.33x | $-45.53 Million | $-47.14 Million | $34.33 Million | ▼ -56.3% |
| 2013 | -0.85x | $-29.06 Million | $-29.61 Million | $34.27 Million | ▼ -2.8% |
| 2012 | -0.82x | $-34.32 Million | $-35.29 Million | $41.61 Million | ▼ -124295.3% |
| 2011 | 0.00x | $52.00K | $-698.00K | $78.29 Million | ▼ -99.8% |
| 2010 | 0.40x | $50.26 Million | $49.94 Million | $125.08 Million | ▲ +150.6% |
| 2009 | -0.79x | $-53.06 Million | $-53.09 Million | $66.86 Million | ▲ +11.3% |
| 2008 | -0.89x | $-72.84 Million | $-74.17 Million | $81.41 Million | ▼ -140.7% |
| 2007 | -0.37x | $-58.71 Million | $-59.33 Million | $157.96 Million | ▲ +71.0% |
| 2006 | -1.28x | $-96.22 Million | $-99.33 Million | $74.96 Million | ▼ -406.8% |
| 2005 | -0.25x | $-23.56 Million | $-30.79 Million | $93.02 Million | ▲ +32.2% |
| 2004 | -0.37x | $-46.84 Million | $-99.99 Million | $125.39 Million | ▼ -169.9% |
| 2003 | 0.53x | $87.57 Million | $37.13 Million | $163.84 Million | ▲ +130.5% |
| 2002 | -1.75x | $-74.06 Million | $-79.36 Million | $42.28 Million | ▼ -248.9% |
| 2001 | -0.50x | $-18.05 Million | $-21.86 Million | $35.96 Million | ▲ +29.5% |
| 2000 | -0.71x | $-16.20 Million | $-18.64 Million | $22.75 Million | ▼ -11.2% |
| 1999 | -0.64x | $-8.20 Million | $-10.30 Million | $12.80 Million | ▲ +22.2% |
| 1998 | -0.82x | $-7.00 Million | $-10.70 Million | $8.50 Million | ▼ -141.2% |
| 1997 | 2.00x | $17.40 Million | $11.00 Million | $8.70 Million | ▲ +25.3% |
| 1996 | 1.60x | $8.30 Million | $6.70 Million | $5.20 Million | — |